FMR LLC & Abigail Johnson Maintain 10.737% Stake in UTMD

Ticker: UTMD · Form: SC 13G/A · Filed: Feb 9, 2024 · CIK: 706698

Utah Medical Products Inc SC 13G/A Filing Summary
FieldDetail
CompanyUtah Medical Products Inc (UTMD)
Form TypeSC 13G/A
Filed DateFeb 9, 2024
Risk Levellow
Sentimentbullish

Complexity: simple

Sentiment: bullish

Topics: institutional-ownership, amendment, medical-devices

TL;DR

**FMR LLC and Abigail Johnson still own over 10% of UTMD, showing strong conviction.**

AI Summary

FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Utah Medical Products Inc. (UTMD) to 10.737% of the common stock, totaling 389,708 shares, as of February 9, 2024. This filing, an amendment to a previous SC 13G, indicates a significant, stable institutional holding. For investors, this signals continued confidence from a large, influential fund in UTMD's long-term prospects, which could be a positive indicator for the stock's stability.

Why It Matters

This filing shows that a major institutional investor, FMR LLC, and its leader, Abigail P. Johnson, continue to hold a substantial portion of Utah Medical Products Inc., suggesting their ongoing belief in the company's value.

Risk Assessment

Risk Level: low — The filing indicates a stable, significant institutional ownership, which generally reduces volatility and provides a vote of confidence in the company.

Analyst Insight

A smart investor would view this stable, significant institutional ownership as a positive signal, potentially indicating long-term value and stability for Utah Medical Products Inc. It might warrant further research into UTMD's fundamentals, given the vote of confidence from a major fund.

Key Numbers

  • 389,708 — Shares Beneficially Owned (Represents the total number of common stock shares of Utah Medical Products Inc. held by FMR LLC and Abigail P. Johnson.)
  • 10.737% — Percent of Class (Indicates the significant portion of Utah Medical Products Inc.'s common stock owned by FMR LLC and Abigail P. Johnson.)

Key Players & Entities

  • FMR LLC (company) — reporting person and parent holding company
  • Abigail P. Johnson (person) — reporting person and principal owner of FMR LLC
  • Utah Medical Products Inc. (company) — the issuer of the common stock
  • 389,708 (dollar_amount) — total shares beneficially owned by FMR LLC and Abigail P. Johnson
  • 10.737% (dollar_amount) — percentage of class beneficially owned

Forward-Looking Statements

  • FMR LLC will maintain a significant ownership stake in Utah Medical Products Inc. for the foreseeable future. (FMR LLC) — high confidence, target: 2025-02-09

FAQ

Who are the primary reporting persons in this SC 13G/A filing?

The primary reporting persons are FMR LLC and Abigail P. Johnson, as stated in Item 1 of the filing.

What percentage of Utah Medical Products Inc.'s common stock do FMR LLC and Abigail P. Johnson beneficially own?

FMR LLC and Abigail P. Johnson beneficially own 10.737% of Utah Medical Products Inc.'s common stock, as detailed in Item 11 and Item 4(b) of the filing.

How many shares of Utah Medical Products Inc. common stock are beneficially owned by the reporting persons?

The reporting persons beneficially own 389,708 shares of Utah Medical Products Inc. common stock, as indicated in Item 7 and Item 4(a) of the filing.

What is the CUSIP number for Utah Medical Products Inc. common stock mentioned in the filing?

The CUSIP number for Utah Medical Products Inc. common stock is 917488108, as stated in the filing's cover page and Item 2(e).

Under which rule is this Schedule 13G filed?

This Schedule 13G is filed pursuant to Rule 13d-1(b), as indicated by the checked box on the cover page and Item 3.

Filing Details

This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 9, 2024 by Abigail P. Johnson regarding UTAH MEDICAL PRODUCTS INC (UTMD).

View full filing on EDGAR

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.